Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma

Influence of rituximab–CHOP therapy on c

Influence of rituximab–CHOP therapy on clinical course and autoimmune parameters in rheumatoid arthritis associated with diffuse large B cell non-Hodgkin lymphoma

✍ Nada Vujasinovic-Stupar; Nada Pejnovic; Olivera Markovic; Goran Babic 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 140 KB

P129 Immunochemotherapy of diffuse large

P129 Immunochemotherapy of diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus

✍ Zs. Simon; Zs. Ress; L. Gergely; T. Tarr; E. Kiss; Á. Illés 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A total of ten patients died, seven due to progressive disease, two due to unrelated cause, and one due to febrile neutropenia. In mantle zone lymphoma the R in combination with fludara (F) and cyclophosphamide (C) resulted CR lasting for 16 months. The patient with CLL is in CR after R-F-C. Conclus

Rituximab in combination with CHOP chemo

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

✍ J. M. Li; L. Wang; Y. Shen; Z. G. Xia; Y. Chen; Q. S. Chen; Y. Chen; X. Y. Zeng; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 161 KB

Rituximab alone was effective for the tr

Rituximab alone was effective for the treatment of a diffuse large B-cell lymphoma associated with hemophagocytic syndrome

✍ Takeshi Sano; Hisashi Sakai; Kengo Takimoto; Hitoshi Ohno 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 438 KB

Activity and safety of dose-adjusted inf

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Antonino Musolino; Daniela Boggiani; Michele Panebianco; Giovanna Vasini; Stefan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views

Activity and safety of dose-adjusted inf

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Alberto Febbri; Alessandro Gozzetti; Luigi Rigacci 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views